Author

Enjiang Wu

Observed name: Enjiang WU

Institution: Shanghai University of Traditional Chinese Medicine

Observed institutions: Chinese Academy of Sciences, State Administration of Traditional Chinese Medicine of the People's Republic of China, Center for Excellence in Brain Science and Intelligence Technology, Shanghai University of Traditional Chinese Medicine, State Key Laboratory of Neuroscience

OpenAlex ID: A5048878296

Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway

2022 · Jiwei Zhang, Jiwei Zhang, et al. · Cancer Letters · 23

Structural insights into gating mechanism and allosteric regulation of NMDA receptors

2023 · Enjiang Wu, Jilin Zhang, et al. · Current Opinion in Neurobiology · 21

Ginsenosides: Allies of gastrointestinal tumor immunotherapy

2022 · Yutao Feng, Fen Ma, et al. · Frontiers in Pharmacology · 10

NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner

2024 · Jiwei Zhang, Fen Ma, et al. · MedComm · 9

Notoginsenoside Ft1 inhibits colorectal cancer growth by increasing CD8+ T cell proportion in tumor-bearing mice through the USP9X signaling pathway

2024 · Yutao FENG, Yuan LI, et al. · Chinese Journal of Natural Medicines · 6

Ginsenoside Rg5 Boost Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade through NF- κB Signaling in Colorectal Cancer

2022 · Jiwei Zhang, Yutao Feng, et al. · Research Square

Works count: 6

Citation count: 69

H-index: 5

I10-index: 3